Isolation and characterization of diverse antimicrobial lipopeptides produced by Citrobacter and Enterobacter
- Santi M Mandal†1,
- Shalley Sharma†2,
- Anil Kumar Pinnaka2,
- Annu Kumari2 and
- Suresh Korpole2Email author
© Mandal et al.; licensee BioMed Central Ltd. 2013
Received: 6 March 2013
Accepted: 3 July 2013
Published: 8 July 2013
Increasing multidrug-resistance in bacteria resulted in a greater need to find alternative antimicrobial substances that can be used for clinical applications or preservation of food and dairy products. Research on antimicrobial peptides including lipopeptides exhibiting both narrow and broad spectrum inhibition activities is increasing in the recent past. Therefore, the present study was aimed at isolation and characterization of antimicrobial lipopeptide producing bacterial strains from fecal contaminated soil sample.
The phenotypic and 16S rRNA gene sequence analysis of all isolates identified them as different species of Gram-negative genera Citrobacter and Enterobacter. They exhibited common phenotypic traits like citrate utilization, oxidase negative and facultative anaerobic growth. The HPLC analysis of solvent extracts obtained from cell free fermented broth revealed the presence of multiple antimicrobial lipopeptides. The comprehensive mass spectral analysis (MALDI-TOF MS and GC-MS) of HPLC purified fractions of different isolates revealed that the lipopeptides varied in their molecular weight between (m/z) 607.21 to 1536.16 Da. Isomers of mass ion m/z 984/985 Da was produced by all strains. The 1495 Da lipopeptides produced by strains S-3 and S-11 were fengycin analogues and most active against all strains. While amino acid analysis of lipopeptides suggested most of them had similar composition as in iturins, fengycins, kurstakins and surfactins, differences in their β-hydroxy fatty acid content proposed them to be isoforms of these lipopeptides.
Although antimicrobial producing strains can be used as biocontrol agents in food preservation, strains with ability to produce multiple antimicrobial lipopeptides have potential applications in biotechnology sectors such as pharmaceutical and cosmetic industry. This is the first report on antibacterial lipopeptides production by strains of Citrobacter and Enterobacter.
Various species of genera like Clostridium, Escherichia, Listeria, Salmonella, Shigella, Staphylococcus and Vibrio[1, 2] are known to cause food spoilage. In addition, different drug resistant strains of Escherichia and Salmonella belonging to family Enterobacteriaceae are reported to cause food-borne illness [3–6]. Increasing multidrug-resistance in bacteria resulted in a greater need to find alternative antimicrobial substances that can be used for various applications including clinical as well as preservation of food and dairy products. Therefore, research on antimicrobial peptides including antimicrobial biosurfactants as a new class of drugs has increased in the recent past as they exhibit both narrow and broad spectrum inhibition activities against Gram-positive and Gram-negative bacteria or fungi. Although members of the Enterobacteriaceae family are known to produce bacteriocins such as enterocins by Enterobacter sp. , serracin by Serratia sp.  bacteriocin by Citrobacter sp.  and microcins by Escherichia sp. , they are not reported to produce any antimicrobial biosurfactants. The different types of biosurfactants with antimicrobial activity include lipopeptides, glycolipids, phospholipids and lipopolysaccharides . While many Gram-positive bacteria including different species of the genus Bacillus are reported to produce diverse antimicrobial lipopeptides with different applications in pharmaceutical and food processing industries , only few lipopeptides have been reported to produce by Gram-negative bacteria like Pseudomonas. The lipopeptides produced by Gram-positive strains have been classified into various types based on their amino acid composition and fatty acid chain length . Similarly, lipopeptides of Pseudomonas also have been grouped into different groups including amphisin, syringomycin, tolaasin and viscosin based on the number and composition of amino acids [13, 15, 16]. Among the several types of biosurfactants, lipopeptides belonging to iturins , surfactins, , fengycins , kurstakins , bacillomycins  and mycosubtilin  displayed therapeutic applications  and they were never reported to produce by any Gram-negative bacteria. Therefore, in the present study we have isolated few Gram-negative bacterial strains belonging to genera Citrobacter and Enterobacter producing antimicrobial lipopeptides from a fecal contaminated soil sample. Further, detailed characterization of these antimicrobial lipopeptides assigned them to iturins, fengycins, kurstakins and surfactins, usually produced by Gram-positive bacteria.
Identification of the lipopeptide producing strains
Isolation and antimicrobial activity of lipopeptides
Determination of minimum inhibitory concentration (MIC) and sensitivity
The MIC analysis of purified lipopeptide fraction Fr-c of strain S-11 revealed 12, 15 and 16 μg/ml concentration for Gram-positive test strains M. luteus, S. aureus and S. epidermidis, respectively. In contrast, Gram-negative test strains like Serratia marcescens and P. aeruginosa exhibited MIC of 20 and 32 μg/ml respectively. Results of heat stability assay of these lipopeptides fractions revealed no reduction in activity even after exposing to temperature of 100°C for 30 min (data not shown).
Mass spectrometry characterization of lipopeptides
List of masses observed in fractionated lipopeptides from different samples obtained in positive ion linear mode
HPLC fraction number
Several reports have described that soil microbes are worthy to be used as the source of different antimicrobial substances including peptides for versatile applications . Most of the antimicrobial peptides produced by diverse bacteria inhibit Gram-positive strains like Listeria monocytogens but not Gram-negative . Among the various peptides, lipopeptides are well known to inhibit the growth of fungi and bacteria including opportunistic pathogens. Consequently, naturally produced antimicrobial lipopeptides have been receiving increased attention due to their anti-infective nature with wide antimicrobial spectrum. Besides the activity of natural peptides, any chemical modifications in structure of these lipopeptide are shown to improve their spectrum and activity. To this effect, daptomycin, an anionic lipopeptide has already been used for therapeutic applications . While antimicrobial lipopeptides are produced by different Gram-positive and Gram-negative bacteria, only lipopeptides produced by species of Pseudomonas and Bacillus have been studied in detail [13, 14, 27–29]. In the present study several antimicrobial substances producing bacterial strains were isolated from a fecal contaminated soil sample and characterization of these substances revealed them as antimicrobial lipopeptides.
The phenotypic features like Gram-negative staining, catalase positive, oxidase negative, facultative anaerobic growth and citrate utilization observed for all strains suggested that they belong to the Enterobacteriaceae family, usually observed in fecal matter. The 16S rRNA gene sequence blast analysis and subsequent phylogentic analysis assigned all strains to different species of the genera Citrobacter and Enterobacter. Interestingly, though strains S-5 and S-9 displayed high identity with E. hormaechei and E. mori respectively in 16S rRNA gene sequence, they only formed an out group to the cluster comprised of different Enterobacter and Citrobacter species (Figure 2). However, the overall topology of neighbour-joining tree revealed the phylogenetic complexity and discrepancies in 16S rRNA gene sequences of strains belonging to the family Enterobacteriaceae. It was also supported by the unusual inclusion of different species belonging to genera Citrobacter and Enterobacter in the same cluster suggesting the need to revisit the family Enterobacteriaceae.
The antimicrobial lipopeptides typically contain a cyclic or linear oligopeptide linked with a β-hydroxy fatty acid tail of varied lengths . Inhibition spectra of these lipopeptides are influenced by the composition of oligopeptide as well as fatty acid component [30, 31]. Antimicrobial lipopeptides are largely produced by Gram-positive bacteria like Bacillus sp. and are classified into different families based on the composition of oligopeptides and antibacterial or antifungal activities . Among the Gram-negative bacteria, Pseudomonas is the only genus reported to produce antimicrobial lipopeptides such as massetolide, viscosin , syringomycin , arthrofactin , pseudodesmins , orfamide  and putisolvin . In addition to these lipopeptides, species like P. fluorescens was reported to produce different massetolide analogues . However, lipopeptides produced by Gram-positive or Gram-negative bacteria had different composition and so far no bacterial strain has been reported to produce reciprocal combinations of lipopeptide composition. Therefore, in the present study we made an attempt to characterize lipopeptides produced by the strains of genera Citrobacter and Enterobacter.
The comprehensive mass spectral (MALDI-TOF MS and GC-MS) analysis of HPLC purified antimicrobial lipopeptides obtained from strains of Citrobacter and Enterobacter revealed the occurrence of different lipopeptide antibiotics belonging to groups like kurstakin, iturin, surfactin and fengycin, usually produced by Gram-positive bacteria. Further, individual lipopeptide belonging to a particular group shown to exhibit differences in their amino acids [13, 27], fatty acid chain length or isomers of fatty acids and thus generating various analogues with varied activity [13, 33]. Accordingly, lipopeptides of the present study showed differences in fatty acid composition and also differed in their antibacterial activity. Of the various lipopeptides, the lipopeptide fraction Fr-b produced by all strains had a molecular weight of 984/985 Da. Although amino acid composition of this peptide identified it as kurstakin, it differed in fatty acid composition (C15) when compared to other kurstakin members that contained fatty acids with chain length of C11-C14, suggesting the lipopeptide fraction (Fr-b) is an isoform of kurstakin. Further, differences in antimicrobial activity spectrum of these peptides attributed to the fatty acid composition differences .
A variety of lipopeptides produced by strains Citrobacter sp. strain S-3 and Enterobacter sp. strain S-11 were identified as lipopeptides belonging to iturin, kurstakin and fengycin with unusual broad spectrum antibacterial activity. It is pertinent to mention that the fraction Fr-e of strains S-3 and S-11, had an identical mass with the lipopeptide reported by Swart and Merwe , therefore, we have minimized further attempt to characterize the full sequence as reported [β-NC14NYNQPNS]. Additionally, identification of C14 fatty acid as the lipid content of the fraction Fr-e also confirmed their classification under iturins as they are known to contain a fatty acid chain length of C14 to C16 along with a cyclic peptide of seven amino acids. Cyclic lipopeptide biosurfactants like iturin, mycosubtilin, surfactin and kurstakin are largely produced by species of Bacillus exhibiting antimicrobial activity [12, 28]. In fact, iturin and fengycin produced by B. subtilis are recognized as potential biopharmaceutical agents due to their antimicrobial and biosurfactant properties . Although different types of lipopeptides varied in their amino acid and/or fatty acid composition, they all are usually thermostable, resistant to proteolytic enzymes and inhibits the growth by altering the membrane integrity. Similarly no reduction in antibacterial activity was observed for fraction Fr-e upon exposing it to 100°C temperature for 30 min suggesting it as heat stable. The amino acid composition analysis of highly active lipopeptide fraction (Fr-c) of strain S-3 and S-11 revealed the sequence as R(C17)EOrnYTEVPEYV which corresponds to linearized fengycin B’2, an isoform produced by a B. subtilis strain . Among the other lipopeptide fractions, Fr-f (m/z 607.21 Da) and Fr-d (m/z 637.23 Da), produced by strains S-3 and S-11, respectively, showed significant antimicrobial activity, but could not be assigned to any lipopeptide family as their molecular mass did not match with any reported antimicrobial lipopeptides. Other mass ions, except m/z 679 Da, produced by different strains did not show significant antimicrobial activity against any test strain. Although iturins, kurstakins, surfactins and fengycins differed in composition, they followed the same mechanisms such as involving pore formation on bacterial membrane  or by other non-specific interactions with the membrane  as a result of their antimicrobial activity. Findings of this study, together with the fact that the entire isolated strains belong to Citrobacter or Enterobacter and antimicrobial lipopeptide production ability, suggests that they are possibly produced by these bacteria as a part of defence mechanism to survive in complex environments.
This is the first report on antibacterial lipopeptides production by strains of Citrobacter and Enterobacter that are part of the human intestinal flora and frequently observed in food. The lipopeptides are exceedingly useful molecules with potential applications in several biotechnology sectors such as pharmaceutical, cosmetic, preservation of food and dairy products. However, engineering of these molecules is very important for our future needs as the large scale production of antimicrobial lipopeptides is expensive. Therefore, strains like S-3 or S-11 with ability to co-produce different antimicrobial lipopeptides are very useful in biotechnology sector. Increased lipopeptides production by these strains through the optimization of physicochemical parameters or transcriptional regulation of lipopeptide synthetase gene clusters could be future insight for commercial production.
Isolation of bacteria and identification
The bacterial isolates designated as S-3, S-4, S-5, S-6, S-7, S-9, S-10, S-11 and S-12 were isolated from a fecal contaminated soil sample. The soil sample used to isolate the strains was serially diluted and plated on nutrient agar with the following composition (g/l): peptic digest of animal tissue, 5.0; beef extract, 1.5; yeast extract, 1.5; sodium chloride, 5.0; agar 15.0 (pH adjusted to 7.2). Colonies with inhibition zone in their surroundings were selected and streaked on to fresh nutrient agar (NA, HiMedia, India) medium plates. Upon testing their purity all isolates were preserved at -70°C for further studies. Indicator strains used to test the activity of lipopeptides were obtained from Microbial Type Culture Collection and Genebank (MTCC), Chandigarh, India. The test strains were grown on tryptone soya agar (TSA) medium with the following composition (g/l): pancreatic digest of casein, 15.0; papaic digest of soybean meal, 5.0; sodium chloride, 5.0; agar 15.0 and the pH adjusted to 7.2. All isolates producing antimicrobial lipopeptides were tested for phenotypic properties including morphology, physiology and biochemical characteristics using standard procedures. The identity of isolates was also confirmed by using 16S rRNA gene sequence  blast search analysis. All 16S rRNA gene sequences of the nearest type strains were downloaded from the NCBI database and aligned using CLUSTAL_W program of MEGA version 5 . The alignment was corrected manually using the BioEdit sequence alignment editor . Pair-wise evolutionary distances were calculated with the Kimura two-parameter  and a neighbour-joining phylogenetic tree was constructed using the MEGA version5.0. The stability of phylogenetic tree was assessed by taking 1000 replicates. All sequences have been submitted to EMBL database [accession nos. HF572835 - HF572843].
Extraction of lipopeptides
Lipopeptides produced by all strains were isolated from culture supernatant by a combination of acid and solvent extraction procedure . In brief, cells were pellet down from the culture broth by centrifugation (13,000 × g) for 15 min at 4°C. The supernatant pH was adjusted to 2.0 by addition of concentrated HCl and allowed to precipitate at 4°C for 16 h. After centrifugation (13,000 × g) for 20 min at 4°C the precipitate was collected and extracted with methanol by stirring for 2 h. The lipopeptide containing methanol was collected after filtration and vacuum-dried.
Purification of lipopeptides
The lipopeptides extracted were dissolved in methanol and fractionated by reverse phase- HPLC (Agilent 1100 series, CA, USA) with a ZORBAX 300-SB18 column (4.6 mm × 250 mm, particle size 5 μm), at a flow rate of 1 ml/min. The solvent system used was (A) 0.1% aqueous TFA and (B) acetonitrile containing 0.1% TFA. The following gradient of solvent B was used to run the column: 0-60% for 0-45 min, 60-80% for 45-55 min and 80-100% for 55-60 min. All peptides eluted from the column were monitored at 215 nm in a diode array detector and all peaks obtained during HPLC were collected using a fraction collector (GILSON, France) that is coupled with the system. These fractions were concentrated by speed vacuum and tested for their antimicrobial activity. The fractions or peaks that showed antibacterial activity were re-chromatographed in the same column under similar conditions, except solvent B was used as 100% acetonitrile with a gradient of 0-10% for 30 min. The peptide concentration was determined using the RP-HPLC conditions and calibrated with surfactin (Sigma-Aldrich, St. Louis, USA).
Antimicrobial assay and MIC determination
All fractions from the reversed phase HPLC were lyophilized, redissolved in MilliQ water to test their antimicrobial activity against S. epidermidis (MTCC435) and P. aeruginosa (ATCC27853) in a microtiter plate assay in triplicates. To examine the bacterial growth or killing rate in the presence of different fractions, bacterial cells were grown in 100 μl of Mueller-Hinton broth (MHB, HiMedia, India) supplemented with fixed concentration (10 μg/ml) of each fraction, at 37°C. Growth or killing rates were determined by measuring OD at 600 nm. The OD values were converted into concentration of cells measured in CFU per millilitre (1.0 OD corresponded to 2.16 × 108 CFU/ml). The MIC of selected biosurfactant/lipopeptide was evaluated for strains S. aureus (MTCC1430), M. luteus (MTCC106) and S. marcescens (MTCC 97) along with P. aeruginosa and S. epidermidis by using a microtiter plate dilution assay in triplicates as described earlier . Test strains were grown to logarithmic phase (between 0.3-0.4 OD) under optimal conditions. The lowest concentration inhibiting the growth of test strain without showing any increase in absorption up to 48 h of incubation was considered as MIC.
MALDI-TOF-MS and sequencing
The purified and active lipopeptides were analysed for molecular mass and MS/MS sequencing by using a Voyager time-of-flight mass spectrometer (Applied Biosystems, Foster City, CA, USA). For MS/MS sequencing, the lactone ring present in lipopeptide was cleaved by incubating each peptide with 10% NaOH in methanol at room temperature for 16 h. The cleaved peptide obtained was lyophilized and again extracted with methanol, and allowed for mass spectrometry analysis. Spectra were recorded in the post-source decay (PSD) ion mode as an average of 100 laser shots with a grid voltage of 75%. The reflector voltage was reduced in 25% steps and guide wire was reduced 0.02–0.01% with an extraction delay time of 100 ns.
Fatty acid analysis by GC-MS
To analyze the fatty acid content associated with the lipopeptides, the peptides (5 mg of each) were incubated with 0.5 ml of 6 M HCl at 90°C for 18 h in sealed tubes for acid hydrolysis. The fatty acids were extracted with ether, treated with 0.95 ml methanol and 0.05 ml of 98% H2SO4 at 65°C for 6 h. Finally, fatty acid methyl esters were obtained with n-hexane extraction and analyzed on GC-MS with a Clarus 500 GC (PerkinElmer, USA). The carrier gas used was helium with a flow rate of 1.0 ml/min. The column temperature was maintained at 120°C for 3 min and thereafter gradually increased (8°C/min) to 260°C.
The statistical significance of the experimental results was determined using one-way ANOVA followed by Dunnett’s test. Values of p<0.05 were considered statistically significant. Prism version 5.0 was used for all statistical analyses. The results are presented as the mean of triplicates (n=3) ± SD.
Financial assistance from Council of Scientific and Industrial Research (CSIR-network project, BSC-0119) and Department of Biotechnology (DBT), Govt of India is acknowledged. We thank Mr. Deepak Bhatt for his help in 16S rRNA gene sequencing. We are also thankful to Ms. Preeti Pathania for technical assistance and Mr. Pradip Kumar Singh for useful discussions.
Note: Nucleotide sequence data reported are available in the DDBJ/EMBL/GenBank databases under the accession numbers HF572835 to HF572843.
- Graveland H, Wagenaar JA, Heesterbeek H, Mevius D, van Duijkeren E, Heederik D: Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS ONE. 2010, 5 (6): e10990-10.1371/journal.pone.0010990.PubMedPubMed CentralView ArticleGoogle Scholar
- Vanderhaeghen W, Hermans K, Haesebrouck F, Butaye P: Methicillin-resistant Staphylococcus aureus (MRSA) in food production animals. Epidemiol Infect. 2010, 138 (5): 606-625. 10.1017/S0950268809991567.PubMedView ArticleGoogle Scholar
- Gorman R, Adley CC: Characterization of Salmonella enterica serotype Typhimurium isolates from human, food, and animal sources in the Republic of Ireland. J Clin Microbiol. 2004, 42 (5): 2314-2316. 10.1128/JCM.42.5.2314-2316.2004.PubMedPubMed CentralView ArticleGoogle Scholar
- Hammerum AM, Heuer OE: Human health hazards from antimicrobial-resistant Escherichia coli of animal origin. Clin Infect Dis. 2009, 48 (7): 916-921. 10.1086/597292.PubMedView ArticleGoogle Scholar
- Vidovic S, Korber DR: Prevalence of Escherichia coli O157 in Saskatchewan cattle: characterization of isolates by using random amplified polymorphic DNA PCR, antibiotic resistance profiles, and pathogenicity determinants. Appl Environ Microbiol. 2006, 72 (6): 4347-4355. 10.1128/AEM.02791-05.PubMedPubMed CentralView ArticleGoogle Scholar
- Zhao S, White DG, Friedman SL, Glenn A, Blickenstaff K, Ayers SL, Abbott JW, Hall-Robinson E, McDermott PF: Antimicrobial resistance in Salmonella enteric serovar Heidelberg isolates from retail meats, including poultry, from 2002 to 2006. Appl Environ Microbiol. 2008, 74 (21): 6656-6662. 10.1128/AEM.01249-08.PubMedPubMed CentralView ArticleGoogle Scholar
- de Graaf FK, Tieze GA, Wendelaar Bonga S, Stouthamer AH: Purification and genetic determination of bacteriocin production in Enterobacter cloacae. J Bacteriol. 1968, 95 (2): 631-640.PubMedPubMed CentralGoogle Scholar
- Jabrane A, Sabri A, Compere P, Jacques P, Vandenberghe I, Van Beeumen J, Thonart P: Characterization of serracin P, a phage-tail-like bacteriocin, and its activity against Erwinia amylovora, the fire blight pathogen. Appl Environ Microbiol. 2002, 68 (11): 5704-5710. 10.1128/AEM.68.11.5704-5710.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Shanks RMQ, Dashiff A, Alster JS, Kadouri DE: Isolation and identification of a bacteriocin with antibacterial and antibiofilm activity from Citrobacter freundii. Arch Microbiol. 2012, 194 (7): 575-587. 10.1007/s00203-012-0793-2.PubMedPubMed CentralView ArticleGoogle Scholar
- Chiuchiolo MJ, Delgado MA, Farias RN, Salomon RA: Growth-phase-dependent expression of the cyclopeptide antibiotic microcin J25. J Bacteriol. 2001, 183 (5): 1755-1764. 10.1128/JB.183.5.1755-1764.2001.PubMedPubMed CentralView ArticleGoogle Scholar
- Parkinson M: Biosurfactants. Biotechnol Adv. 1985, 3 (1): 65-83. 10.1016/0734-9750(85)90006-0.PubMedView ArticleGoogle Scholar
- Rodrigues L, Banat IM, Teixeira J, Oliveira R: Biosurfactants: potential applications in medicine. J Antimicrob Chemother. 2006, 57 (4): 609-618. 10.1093/jac/dkl024.PubMedView ArticleGoogle Scholar
- Nybroe O, Sørensen J: Production of cyclic lipopeptides by fluorescent pseudomonads. Pseudomonas, Biosynthesis of Macromolecules and Molecular Metabolism. Edited by: Ramos J-L. 2004, New York: Kluwer Academic/Plenum Publishers, 147-172.Google Scholar
- Ongena M, Jacques P: Bacillus lipopeptides: versatile weapons for plant disease biocontrol. Trends Microbiol. 2008, 16 (3): 115-125. 10.1016/j.tim.2007.12.009.PubMedView ArticleGoogle Scholar
- Bender CL, Scholz-Schroeder BK: New insights into the biosynthesis, mode of action and regulation of syringomycin, syringopeptin and coronatine. Pseudomonas Vol2, Virulence and Gene Regulation Volume 2. Edited by: Ramos J-L. 2004, New York: Kluwer Academic/Plenum Publishers, 125-158.Google Scholar
- Gross H, Loper JE: Genomics of secondary metabolite production by Pseudomonas spp. Nat Prod Rep. 2009, 26 (11): 1408-1446. 10.1039/b817075b.PubMedView ArticleGoogle Scholar
- Delcambe L, Peypoux F, Besson F, Guinand M, Michel G: Structure of iturin-like substances. Biochem Soc Trans. 1977, 5: 1122-1124.PubMedView ArticleGoogle Scholar
- Arima K, Kakinuma A, Tamura G: Surfactin, a crystalline peptide lipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem Biophys Res Commun. 1968, 31 (3): 488-494. 10.1016/0006-291X(68)90503-2.PubMedView ArticleGoogle Scholar
- Vanittanakom N, Loeffler W, Koch U, Jung G: Fengycin- a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot. 1986, 39 (7): 888-901. 10.7164/antibiotics.39.888.PubMedView ArticleGoogle Scholar
- Hathout Y, Ho Y-P, Ryzhov V, Demirev P, Fenselau C: Kurstakins: a new class of lipopeptides isolated from Bacillus thuringiensis. J Nat Prod. 2000, 63 (11): 1492-1496. 10.1021/np000169q.PubMedView ArticleGoogle Scholar
- Roongsawang N, Thaniyavarn J, Thaniyavarn S, Kameyama T, Haruki M, Imanaka T, Morikawa M, Kanaya S: Isolation and characterization of halotolerant Bacillus subtilis BBK-1 which produces three kinds of lipopeptides: bacillomycin L, plipastatin and surfactin. Extremophiles. 2002, 6 (6): 499-506. 10.1007/s00792-002-0287-2.PubMedView ArticleGoogle Scholar
- Duitman HE, Hamoen LW, Rembold M, Venema G, Seitz H, Saenger W, Bernhard F, Reinhard R, Schmidt M, Ullrich C, Stein T, Leenders F, Vater J: The mycosubtilin synthetase of Bacillus subtilis ATCC6633: A multifunctional hybrid between a peptide synthetase, an amino transferase and a fatty acid synthase. Proc Natl Acad Sci USA. 1999, 96 (23): 13294-13299. 10.1073/pnas.96.23.13294.PubMedPubMed CentralView ArticleGoogle Scholar
- Besson F, Michel G: Biosynthesis of iturin and surfactin by Bacillus subtilis: evidence for amino acid activating enzymes. Biotechnol Lett. 1992, 14 (11): 1013-1018. 10.1007/BF01021050.View ArticleGoogle Scholar
- Mandal SM, Barbosa AE, Franco OL: Lipopeptides in microbial infection control: scope and reality for industry. Biotechnol Adv. 2013, 10.1016/j.biotechadv.2013.01.004. (In press), S0734-9750(13)00006-2.Google Scholar
- Abee T, Krockel L, Hill C: Bacteriocins: modes of action and potentials in food preservation and control of food poisoning. Int J Food Microbiol. 1995, 28 (2): 169-185. 10.1016/0168-1605(95)00055-0.PubMedView ArticleGoogle Scholar
- Tally FP, De Bruin MF: Development of daptomycin for Gram-positive infections. J Antimicrob Chemother. 2000, 46 (4): 523-526. 10.1093/jac/46.4.523.PubMedView ArticleGoogle Scholar
- Baindara P, Mandal SM, Chawla N, Singh PK, Pinnaka AK, Korpole S: Characterization of two antimicrobial peptides produced by a halotolerant Bacillus subtilis strain SK.DU.4 isolated from a rhizosphere soil sample. AMB Express. 2013, 3 (1): 2-10.1186/2191-0855-3-2.PubMedPubMed CentralView ArticleGoogle Scholar
- Raaijmakers JM, De Bruijn I, Nybroe O, Ongena M: Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics. FEMS Microbiol Rev. 2010, 34 (6): 1037-1062.PubMedView ArticleGoogle Scholar
- Raaijmakers JM, De Bruijn I, de Kock JD: Cyclic lipopeptide production by plant-associated Pseudomonas spp. diversity, activity, biosynthesis and regulation. Mol Plant Microbe Interact. 2006, 19 (7): 699-710. 10.1094/MPMI-19-0699.PubMedView ArticleGoogle Scholar
- Jerala R: Synthetic lipopeptides: a novel class of antiinfectives. Expert Opin Investig Drugs. 2007, 16 (8): 1159-1169. 10.1517/135437188.8.131.529.PubMedView ArticleGoogle Scholar
- Makovitzki A, Avrahami D, Shai Y: Ultrashort antibacterial and antifungal lipopeptides. Proc Natl Acad Sci USA. 2006, 103 (43): 15997-16002. 10.1073/pnas.0606129103.PubMedPubMed CentralView ArticleGoogle Scholar
- Price NPJ, Rooney AP, Swezey JL, Perry E, Cohan FM: Mass spectrometric analysis of lipopeptides from Bacillus strains isolated from diverse geographical locations. FEMS Microbiol Lett. 2007, 271 (1): 83-89. 10.1111/j.1574-6968.2007.00702.x.PubMedView ArticleGoogle Scholar
- De Bruijn I, de Kock MJ, de Waard P, van Beek TA, Raaijmakers JM: Massetolide A biosynthesis in Pseudomonas fluorescens. J Bacteriol. 2008, 190 (8): 2777-2789. 10.1128/JB.01563-07.PubMedPubMed CentralView ArticleGoogle Scholar
- Dumenyo CK, Mukherjee A, Chun W, Chatterjee AK: Genetic and physiological evidence for the production of N-acyl homoserine lactones by Pseudomonas syringae pv. syringae and other fluorescent plant pathogenic Pseudomonas species. Eur J Plant Pathol. 1998, 104 (6): 569-582. 10.1023/A:1008651300599.View ArticleGoogle Scholar
- Roongsawang N, Hase K, Haruki M, Imanaka T, Morikawa M, Kanaya S: Cloning and characterization of the gene cluster encoding arthrofactin synthetase from Pseudomonas sp. MIS38. Chem Biol. 2003, 10 (9): 869-880. 10.1016/j.chembiol.2003.09.004.PubMedView ArticleGoogle Scholar
- Sinnaeve D, Michaux C, Van Hemel J, Vandenkerckhove J, Peys E, Borremans FAM, Sas B, Wouters J, Martins JC: Structure and X-ray conformation of pseudodesmins A and B, two new cyclic lipodepsipeptides from Pseudomonas bacteria. Tetrahedron. 2009, 65 (21): 4173-4181. 10.1016/j.tet.2009.03.045.View ArticleGoogle Scholar
- Dubern JF, Lugtenberg BJ, Bloemberg GV: The ppulrsaL-ppuR quorum-sensing system regulates biofilm formation of Pseudomonas putida PCL1445 by controlling biosynthesis of the cyclic lipopeptides putisolvins I and II. J Bacteriol. 2006, 188 (8): 2898-2906. 10.1128/JB.188.8.2898-2906.2006.PubMedPubMed CentralView ArticleGoogle Scholar
- Swart MRP, van der Merwe MJ: Sequence specific stabilization of a linear analog of the antifungal lipopeptide iturin A2 by sodium during low energy electrospray ionization mass spectrometry conditions. J Am Soc Mass Spectrom. 2001, 12 (5): 505-516. 10.1016/S1044-0305(01)00232-X.PubMedView ArticleGoogle Scholar
- Hourdou ML, Besson F, Tenoux I, Michel G: Fatty acids and β-amino acid syntheses in strains of Bacillus subtilis producing iturinic antibiotics. Lipids. 1989, 24 (11): 940-944. 10.1007/BF02544538.PubMedView ArticleGoogle Scholar
- Pathak KV, Keharia H, Gupta K, Thankur SS, Balaram P: Lipopeptides from the Banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins. J Am Soc Mass Spectrom. 2012, 23 (10): 1716-1728. 10.1007/s13361-012-0437-4.PubMedView ArticleGoogle Scholar
- Deleu M, Paquot M, Nylander T: Fengycin interaction with lipid monolayers at the air-aqueous interface implications for the effect of fengycin on biological membranes. J Colloid Interface Sci. 2005, 283 (2): 358-365. 10.1016/j.jcis.2004.09.036.PubMedView ArticleGoogle Scholar
- Bessalle R, Kapitkovsky A, Gorea A, Shalit I, Fridkin M: All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 1990, 274 (1–2): 151-155.PubMedView ArticleGoogle Scholar
- Suresh K, Mayilraj S, Chakrabarti T: Effluviibacter roseus gen. nov. sp. nov., isolated from muddy water, belonging to the family “Flexibacteraceae”. Int J Syst Evol Microbiol. 2006, 56 (7): 1703-1707. 10.1099/ijs.0.64144-0.PubMedView ArticleGoogle Scholar
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol Biol Evol. 2011, 28 (10): 2731-2739. 10.1093/molbev/msr121.PubMedPubMed CentralView ArticleGoogle Scholar
- Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser. 1999, 41: 95-98.Google Scholar
- Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980, 16 (2): 111-120. 10.1007/BF01731581.PubMedView ArticleGoogle Scholar
- Vater J, Kablitz B, Wilde C, Franke P, Mehta N, Cameotra SS: Matrix-assisted laser desorbtion ionization-time of flight mass spectrometry of lipopeptide biosurfactants in whole cells and culture filtrates of Bacillus subtilis C-1 isolated from petroleum sludge. Appl Environ Microbiol. 2002, 68 (12): 6210-6219. 10.1128/AEM.68.12.6210-6219.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Singh PK, Chittpurna A, Sharma V, Patil PB, Suresh K: Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. Strain GI-9. PLoS ONE. 2012, 7 (3): e31498-10.1371/journal.pone.0031498.PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.